日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells

Kisspeptin 介导的维莫非尼耐药黑色素瘤细胞对 BRAF 抑制剂敏感性的提高

Carlotta Guzzetti, Cristina Corno, Elisabetta Vergani, Luca Mirra, Emilio Ciusani, Monica Rodolfo, Paola Perego, Giovanni L Beretta

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma

针对脂质代谢可削弱黑色素瘤对 BRAF 激酶抑制剂的耐药性

Elisabetta Vergani, Giovanni L Beretta, Mariachiara Aloisi, Matteo Costantino, Cristina Corno, Simona Frigerio, Stella Tinelli, Matteo Dugo, Felice Maria Accattatis, Agnese Granata, Lorenzo Arnaboldi, Monica Rodolfo, Paola Perego, Laura Gatti

Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation

人类黑色素瘤细胞在性激素刺激下差异表达 RNASEL/RNase-L 和 miR-146a-5p

Elisa Orlandi, Elisa De Tomi, Rachele Campagnari, Francesca Belpinati, Monica Rodolfo, Elisabetta Vergani, Giovanni Malerba, Macarena Gomez-Lira, Marta Menegazzi, Maria Grazia Romanelli

Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients

综合转录表型分析捕获肾细胞癌患者抗血管生成治疗后的全身免疫调节

Darawan Rinchai, Elena Verzoni, Veronica Huber, Agata Cova, Paola Squarcina, Loris De Cecco, Filippo de Braud, Raffaele Ratta, Matteo Dugo, Luca Lalli, Viviana Vallacchi, Monica Rodolfo, Jessica Roelands, Chiara Castelli, Damien Chaussabel, Giuseppe Procopio, Davide Bedognetti, Licia Rivoltini

Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug Combinations

BRAF 抑制剂耐药黑色素瘤细胞中失调的 FASN 表达揭示了药物组合的新靶点

Serena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, Matteo Dugo, Cristina Corno, Elisabetta Corna, Stella Tinelli, Simona Frigerio, Emilio Ciusani, Monica Rodolfo, Paola Perego, Laura Gatti

Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma

靶向 p63 上调可消除黑色素瘤对 MAPK 抑制剂的耐药性

Ankit Patel, Lucia Fraile Garcia, Viviana Mannella, Luke Gammon, Tiffanie-Marie Borg, Tania Maffucci, Maria Scatolini, Giovanna Chiorino, Elisabetta Vergani, Monica Rodolfo, Andrea Maurichi, Christian Posch, Rubeta N Matin, Catherine A Harwood, Daniele Bergamaschi

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response

进展性黑色素瘤患者前哨淋巴结中的 microRNA 表达可识别与免疫反应功能障碍相关的网络

Viviana Vallacchi, Chiara Camisaschi, Matteo Dugo, Elisabetta Vergani, Paola Deho, Ambra Gualeni, Veronica Huber, Annunziata Gloghini, Andrea Maurichi, Mario Santinami, Marialuisa Sensi, Chiara Castelli, Licia Rivoltini, Monica Rodolfo

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

组蛋白去乙酰化酶抑制剂-替莫唑胺联合治疗通过抑制趋化因子 (CC 基序) 配体 2 驱动信号来抑制黑色素瘤生长

Laura Gatti, Alexandra Sevko, Michelandrea De Cesare, Noemi Arrighetti, Giacomo Manenti, Emilio Ciusani, Paolo Verderio, Chiara M Ciniselli, Denis Cominetti, Nives Carenini, Elisabetta Corna, Nadia Zaffaroni, Monica Rodolfo, Licia Rivoltini, Viktor Umansky, Paola Perego

Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032

鉴定对 PLX4032 有原发性耐药性的黑色素瘤细胞系中的 MET 和 SRC 活性

Elisabetta Vergani, Viviana Vallacchi, Simona Frigerio, Paola Deho, Piera Mondellini, Paola Perego, Giuliana Cassinelli, Cinzia Lanzi, Maria Adele Testi, Licia Rivoltini, Italia Bongarzone, Monica Rodolfo

Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress

DHCR24/Seladin-1 在急性和慢性氧化应激反应中的促存活作用

Katrin Kuehnle, Arames Crameri, Roland E Kälin, Paola Luciani, Susanna Benvenuti, Alessandro Peri, Francesca Ratti, Monica Rodolfo, Luka Kulic, Frank L Heppner, Roger M Nitsch, M Hasan Mohajeri